Prometic and Top Meadows establish joint venture for development of Mad Cow Disease diagnostics
Kym Anthony, newly elected Director of ProMetic Life Sciences Inc. and President of Top Meadow, has agreed to invest through Top Meadow the initial seed investment to bring the joint venture's first ante-mortem veterinary blood-based diagnostic product to market. First Associates Investments Inc. acted as advisor to the parties for the formation of the joint venture and has initiated financing activities to raise additional funds.
Mr. Anthony will act as non-executive Chairman of the new joint venture which will attract additional seasoned executives with specific and complementary expertise in the field of diagnostics and veterinary medicine. Pierre Laurin will act as interim CEO. The joint venture will rely on the unique expertise of PRDT's scientists, namely Dr. Robert Rohwer, a renowned expert on prions affiliated with the University of Maryland, Dr. David Hammond, Chairperson of the Scientific Advisory Committee of PRDT and an Executive Director at the American Red Cross, Dr. Ruben Carbonell, Director of the Kenan Institute for Engineering, Technology & Science at North Carolina State University, and Dr. Peter Edwardson, Project Director, PRDT, who will work closely with scientists, regulatory and government officials.
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.